×


 x 

Shopping cart
Patricia Mcgrath - Zebrafish: Methods for Assessing Drug Safety and Toxicity - 9780470425138 - V9780470425138
Stock image for illustration purposes only - book cover, edition or condition may vary.

Zebrafish: Methods for Assessing Drug Safety and Toxicity

€ 131.23
FREE Delivery in Ireland
Description for Zebrafish: Methods for Assessing Drug Safety and Toxicity Hardcover. This book describes methods for using the zebrafish as a model organism to assess compound-induced toxicity on all major organs, including the heart, liver, gut, pancreas, kidney, CNS, PNS, motor neurons, eye, ear, hematopoietic system, immune system, and overall development. Editor(s): McGrath, Patricia. Num Pages: 352 pages, Illustrations (some col.). BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 164 x 243 x 23. Weight in Grams: 660.
Zebrafish: Methods for Assessing Drug Safety and Toxicity offers a practical guide for using zebrafish as a tool for toxicology studies. 

Consolidating key protocols and approaches to help researchers navigate the important and evolving field of zebrafish models for toxicity screening, this new title describes the methods for using the zebrafish as a model organism to assess compound-induced toxicity on all major organs.  Individual chapters that concentrate on assays for each organ system are included and various analytical tools including microscopy, microplate readers, high content imaging systems, ECG, blood pressure monitors, high speed video and motion detectors are described.

... Read more

Product Details

Format
Hardback
Publication date
2012
Publisher
John Wiley & Sons Inc United Kingdom
Number of pages
352
Condition
New
Number of Pages
352
Place of Publication
New York, United States
ISBN
9780470425138
SKU
V9780470425138
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50

About Patricia Mcgrath
Patricia McGrath, MBA, is President and CEO of Phylonix Pharmaceuticals, Inc. She has some twenty-five years of experience in high-tech and biotechnology management. Phylonix Pharmaceuticals develops and markets novel in vivo zebrafish-based assays for therapeutic and industrial screening for cancers, central nervous system and cardiovascular diseases, apoptosis, and toxicity.

Reviews for Zebrafish: Methods for Assessing Drug Safety and Toxicity
“This book should prove a useful reference for students, researchers and biomedical science professionals working with this species as an evolving model for toxicity assessment.”  (British Toxicology Society New, 1 November 2012)

Goodreads reviews for Zebrafish: Methods for Assessing Drug Safety and Toxicity


Subscribe to our newsletter

News on special offers, signed editions & more!